A revolutionary oral HBV treatment candidate as innovative therapeutic approach warranting clinical trials
Crossref DOI link: https://doi.org/10.1007/s00535-024-02091-1
Published Online: 2024-03-25
Published Print: 2024-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Matsui, Takeshi
Text and Data Mining valid from 2024-03-25
Version of Record valid from 2024-03-25
Article History
Received: 23 February 2024
Accepted: 28 February 2024
First Online: 25 March 2024
Free to read: This content has been made available to all.